Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Barry Gach

Gastroenterology Boynton Beach, FL Medical Doctor

NPI 1699700070 CMS profile 304005

1325 S Congress Ave, Suite 211, Boynton Beach, FL 33426

Open in the dashboard

General payments

$6,467

322 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Barry Gach of Boynton Beach, FL is reported in the CMS Open Payments database as having received $6,467 across 322 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,350 43
2024 General $725 25
2023 General $445 25
2022 General $1,163 61
2021 General $899 63
2020 General $781 47
2019 General $1,103 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Barry Gach
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Barry Gach were reported at $1,350. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Barry Gach Gastroenterology median Middle half National median
2019 $1,103 $417 $126–$1,100 $163
2020 $781 $224 $74–$624 $114
2021 $899 $352 $106–$1,054 $132
2022 $1,163 $448 $129–$1,270 $149
2023 $445 $533 $150–$1,390 $160
2024 $725 $605 $160–$1,606 $164
2025 $1,350 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,424 83 payments
  2. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,220 84 payments
  3. Janssen Biotech, Inc. $739 16 payments
  4. Gilead Sciences, Inc. $486 20 payments
  5. Romark Laboratories, LC $394 22 payments
  6. Pfizer Inc. $311 8 payments
  7. Merck Sharp & Dohme Corporation $224 12 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $202 9 payments
  9. RedHill Biopharma Inc. $196 11 payments
  10. Madrigal Pharmaceuticals $158 5 payments
  11. Other $1,112 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,368 321 payments
  2. Education $99 1 payment
Products named General payments · program years 2019–2025
  1. XIFAXAN $1,119 83 payments
  2. CREON $964 65 payments
  3. LINZESS $624 38 payments
  4. TREMFYA $470 7 payments
  5. ALINIA Gastroenterology $394 22 payments
  6. ALINIA Gastroenterology $394 22 payments
  7. ALINIA Gastroenterology $394 22 payments
  8. STELARA $393 10 payments
  9. VELSIPITY $311 8 payments
  10. ZENPEP $232 14 payments
  11. Other $3,057 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

465

Median for Gastroenterology: 569

Drug cost

$23,665

Median for Gastroenterology: $104,976

Branded share of claims

5.4%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Trulance Plecanatide Brand 12 $6,948
Dexlansoprazole Dr Dexlansoprazole Brand 13 $5,715
Famotidine Generic 138 $3,142
Pantoprazole Sodium Generic 141 $1,978
Sucralfate Generic 47 $1,897
Entecavir Generic 12 $1,249
Omeprazole Generic 60 $1,223
Dicyclomine Hcl Generic 13 $518
Esomeprazole Magnesium Generic 15 $505
Metronidazole Generic 14 $491

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$88,464

Medicare's payments for the services billed

Medicare patients

209

Average age 78

Services billed

1,038

123 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 48%
Chronic kidney disease 42%
Atrial fibrillation 28%
Depression 28%
Diabetes 26%
Cancer 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
STELARA
  • Janssen Biotech, Inc. $151
$151 — —
RINVOQ
  • AbbVie, Inc. $136
$136 — —
TREMFYA
  • Janssen Biotech, Inc. $92
$92 — —
CREON
  • AbbVie, Inc. $70
$70 — —
DIFICID
  • Merck Sharp & Dohme Corporation $64
$64 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

322 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record